Daratumumab in Primary Effusion Lymphoma

N Engl J Med. 2018 Aug 16;379(7):689-690. doi: 10.1056/NEJMc1806295.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • ADP-ribosyl Cyclase 1 / metabolism
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Bone Marrow / pathology
  • HIV Infections / complications
  • Herpesvirus 8, Human / isolation & purification
  • Humans
  • Lymphoma, Primary Effusion / drug therapy*
  • Lymphoma, Primary Effusion / therapy
  • Lymphoma, Primary Effusion / virology
  • Male
  • Middle Aged
  • Recurrence
  • Viral Load

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • daratumumab
  • ADP-ribosyl Cyclase 1